NorthWest Biotherapeutics Inc (NWBO)

[iwasadiver]

I believe it’s quite possible Merck was recently told to “go f*** yourself” by LP and are now far behind. Why go through the difficult process of identifying numerous antigen proteins, create a specific sequence of mRNA for each, and then hope by injecting it the patient’s own DCs will find it, replicate the proteins, and present them on their cell surface? We’ve already seen failed vaccines using selective antigens. Sounds desperate.

Now, what if someone like Roche partners with NWBO and Regeneron (TLR agonist) for the “Keep It Simple Stupid” version for the win? I like this scenario frankly; although it’s possible Merck may want to JV with NWBO for the Dendritic Cells as the carrier for the mRNA. But I don’t think so